Cargando…
In vitro and in vivo evaluation of a novel bioresorbable magnesium scaffold with different surface modifications
The novel Resoloy® rare earth magnesium alloy was developed for bioresorbable vascular implant application, as an alternative to the WE43 used in Biotronik's Magmaris scaffold, which received CE approval in 2016. Initially, the Magmaris showed very promising preclinical and clinical results, bu...
Autores principales: | Menze, Roman, Wittchow, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359236/ https://www.ncbi.nlm.nih.gov/pubmed/33386677 http://dx.doi.org/10.1002/jbm.b.34790 |
Ejemplares similares
-
In vitro and in vivo degradation of microfiber bioresorbable coronary scaffold
por: Huang, Chi‐Hung, et al.
Publicado: (2017) -
In vivo degradation and endothelialization of an iron bioresorbable scaffold
por: Lin, Wenjiao, et al.
Publicado: (2020) -
Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease
por: Campos, Carlos M., et al.
Publicado: (2013) -
Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation
por: Opolski, Maksymilian P., et al.
Publicado: (2018) -
Serial invasive imaging follow‐up of the first clinical experience with the Magmaris magnesium bioresorbable scaffold
por: Tovar Forero, Maria Natalia, et al.
Publicado: (2019)